Chile

Study populations

Chile, in 2016, had an estimated population of 18.1m with 20% under the age of 15 years and 11% aged 65 years and over. By 2050, total population will increase to 216m with those under the age of 15 years making up 14% while one in four (26%, 5.6m) will be 65 years or older.

Alongside the ageing population, the prevalence of people with diabetes appears to be increasing – with the most recent statistics reporting 1.4m people living with diabetes and an estimated 470,800 undiagnosed cases.

Report & Infographic

Cover page for Chile Study Report. For accessible PDF version of full report click the image.

Info-graphic containing overview of findings. For an accessible PDF please click the image.

Time of presentation for screening with an opthamologist

25% In time for screening, 75% When visual problems have already occurred, 0% Too late for effective treatment

(Opthamologists n=10)

In time for screening When visual problems have already occurred Too late for effective treatment

Availability of DR patient education materials in health care providers’ offices

15% Sufficient information available, 35% Information not sufficient, 40% No written information available, 10% Don’t know

(All providers n=20)

Sufficient information available Information not sufficient No written information available Don’t know

Complications adults with diabetes were most concerned about

68.4% Vision loss, 15.8% Amputation, 15.8% Kidney disease

(Adults with diabetes n=18)

Vision loss Amputation Kidney disease

Frequency of discussions about eye complications with health care providers

21.1% Every visit, 5.3% Multiple times per year, 31.6% Once a year, 36.8% When symptoms arise, 5.3% Never

(Adults with diabetes n=19)

Every visit Multiple times per year Once a year When symptoms arise Never

Join the DR Community

The DR Barometer Community is a growing multidisciplinary network of thought leaders and organizations who are working together to address gaps in diabetes patient care. Join today to help improve vision health outcomes among people living with diabetes.